(S)-3-(3-(1-(2-(isopropyl(phenyl)amino)-2-oxoethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)ureido)benzoic acid

Catalog No. :
ACGZYS962
CAS No. :
305366-98-7
Molecular Formula :
C34H31N5O6
Molecular Weight :
605.65

IUPAC Name:(S)-3-(3-(1-(2-(isopropyl(phenyl)amino)-2-oxoethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)ureido)benzoic acid

(S)-3-(3-(1-(2-(isopropyl(phenyl)amino)-2-oxoethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)ureido)benzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-3-(3-(1-(2-(isopropyl(phenyl)amino)-2-oxoethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)ureido)benzoic acid
IUPAC Name(S)-3-(3-(1-(2-(isopropyl(phenyl)amino)-2-oxoethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)ureido)benzoic acid
Molecular FormulaC34H31N5O6
Molecular Weight605.65
SMILESCC(C)N(C(=O)CN1C(=O)[C@H](NC(=O)NC2=CC=CC(C(=O)O)=C2)C(=O)N(C2=CC=CC=C2)C2=CC=CC=C21)C1=CC=CC=C1
InChI KeyCABBMMXFOOZVMS-PMERELPUSA-N
SynonymGI 181771;CABBMMXFOOZVMS-PMERELPUSA-N;Benzoic acid, 3-[[[[(3S)-2,3,4,5-tetrahydro-1-[2-[(1-methylethyl)phenylamino]-2-oxoethyl]-2,4-dioxo-5-phenyl-1H-1,5-benzodiazepin-3-yl]amino]carbonyl]amino]-;GI181771X
CAS No.305366-98-7

Synthetic Route by SureRoute

1. ACGZYS962 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGZYS962 route product structure diagram
    ACGZYS962305366-98-7
Inquiry

2. ACGZYS962 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGZYS962 route product structure diagram
    ACGZYS962305366-98-7
Inquiry

Comments (0)